Developer docs
API playgroundTry for free, no card

Search company profiles

P1 Trials

Full company profile

uuid0003k1d

Namestring
P1 Trials
Legal namestring
P1 Trials, Inc.
Websiteurl
p1trials.com
Company typeenum
Private
Founded yearint
2024
Descriptiontext

P1 Trials (rebranded as P1 Pratia Oncology in December 2025) is a Seattle-headquartered, Delaware-incorporated clinical research site network that enables community-based oncology clinics to conduct complex Phase 1 oncology trials. The company operates as a managed-services intermediary, providing eight integrated service modules — feasibility assessments, regulatory support, contracts and budgets, financial management, business development, technology integration, quality management, and patient matching/screening — to community oncology practices that lack the infrastructure to run early-phase studies independently. P1 Trials' stated mission is to bring investigational therapies closer to patients outside academic medical centers by bridging sponsor demand with community-site supply.

The platform is built on a centralized infrastructure layer that includes a Clinical Trial Management System (CTMS) and an AI-based patient matching recommendation engine that processes structured patient data to identify relevant trial opportunities across the network. Service delivery is handled through direct enterprise sales to pharmaceutical sponsors and CROs, with industry conferences used as a secondary channel for business development. The customer base is dual-sided: pharmaceutical sponsors seeking faster enrollment and access to community-based patient populations, and community oncology clinics seeking the operational scaffolding, regulatory expertise, and sponsor relationships needed to participate in Phase 1 research.

Revenue is generated through quote-based B2B managed-services arrangements with pharmaceutical sponsors and CROs, monetized via per-trial service fees and centralized operational support for affiliated community clinics. In December 2025, P1 Trials joined Pratia, a global early-phase oncology research site network, and rebranded as P1 Pratia Oncology; Pratia now functions as the parent operating company, granting P1 multi-geography sponsor access and shared operational infrastructure. The company has raised $5,454,015 in an SEC Rule 506(b) exempt equity offering with a single investor, with first sale recorded on November 26, 2025.

Short descriptiontext

P1 Trials (now P1 Pratia Oncology) is a Seattle-based clinical research site network that enables community oncology clinics to run Phase 1 oncology trials, providing centralized regulatory, financial, technology, and AI patient-matching services to both clinics and pharmaceutical sponsors.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersSeattle, United States
HQ citystring
Seattle
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
Phase 1 oncology trials, clinical trial site network, community oncology research, patient trial matching, clinical research services
Industry5 codes
PRIMARYHLAGACAE
Clinical Trial Site Operations & Study Coordination
SECONDARYHLAIALAE
Clinical Development (Phase I–III Trial Design & Execution)
Healthcare & Life Sciences/Pharmaceuticals/Pharmaceutical Research and Development
SECONDARYHLAGACAC
Clinical Site Start-Up & Activation (Regulatory/Ethics/Contracts)
SECONDARYHLAGACAM
Clinical Trial Financial Management & Payments (Site Budgeting)
SECONDARYHLAAANAI
Precision Clinical Trials Enablement (patient matching, site matching, adaptive trials)
NAICS code2 codes
  • Offices of Physicians62111
  • Scientific Research and Development Services5417
SIC code2 codes
  • Services-Health Services8000
  • Services-Specialty Outpatient Facilities, Nec8093
Product category
Clinical Research Services
No data
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Clinical Trial Support Services
TypeManaged Services
Description

P1 Trials generates revenue by providing centralized services to community oncology clinics conducting Phase 1 clinical trials. Services include feasibility assessments, regulatory support, contracts and budgets, financial management, business development, technology integration, quality management, and patient matching. The company acts as an intermediary between pharmaceutical sponsors seeking trial sites and community clinics seeking trial opportunities.

p1trials.com
Marketing channels2 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Operations, Technology or R&D, Marketing or Sales
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

P1 Trials operates a centralized, community-based oncology clinic network purpose-built to run Phase 1 clinical trials. It delivers feasibility, regulatory, contracts and budget, financial management, business development, technology integration, quality management, and clinic enablement services, augmented by AI-powered patient matching, giving sponsors access to community oncology patient populations that traditional academic centers typically do not reach.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

P1 Trials (now P1 Pratia Oncology) operates as a unified platform for Phase 1 oncology clinical trials, combining a network of community-based oncology clinics with centralized infrastructure services. The platform comprises eight integrated service modules: Feasibility Assessments, Regulatory Support, Contracts & Budgets, Financial Management, Business Development, Technology Integration, Quality Management, and Patient Matching & Screening. Together, these services enable community clinics to participate in Phase 1 clinical trials by handling operational complexities, regulatory compliance, financial processes, and patient recruitment—allowing clinics to focus on patient care while the centralized infrastructure manages trial execution.

Product and service1 record
1Phase 1 Oncology Clinical Trial Site Network Services
Scale indicator2 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-12-01
Description

In December 2025, P1 Trials joined Pratia, expanding reach and capabilities as part of a global early-phase oncology Research Site Network. The partnership enables P1 Trials (now P1 Pratia Oncology) to leverage Pratia's global network infrastructure while maintaining its focus on community-based oncology clinics in the US.

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
1Sarah Cannon Research Institute (SCRI)
TypeDirect peer
Description

One of the largest Phase 1 oncology site networks in the US, operating dedicated early-phase units across multiple cities. Directly comparable as a multi-site Phase 1 oncology research organization targeting pharmaceutical sponsors.

TypeDirect peer
Description

Network of dedicated Phase 1 oncology centers conducting first-in-human and early-phase trials. Highly comparable business model focused on early-phase oncology trial execution and sponsor access.

TypeDirect peer
Description

Global early-phase oncology research organization running Phase 1 trials across multiple sites. Directly comparable as a Phase 1-focused oncology site network serving pharma sponsors.

TypeDirect peer
Description

Phase 1 oncology research site network with multiple community-based locations across Florida. Comparable as a multi-site Phase 1 oncology site operator targeting pharma sponsors.

TypeEmerging player
Description

Innovative research network of independent oncology practices; an advisor to P1 (Sibel Blau, MD) is a founding member. Comparable model aggregating independent community oncology clinics for clinical research.

TypeEmerging player
Description

National organization focused on community oncology research, value-based care, and education; P1 leadership has prior involvement. Comparable as a community oncology research network and ecosystem peer.

TypeBroad incumbent
Description

Global CRO with dedicated site management and oncology clinical trial services. Comparable as a broad incumbent offering site-network services to pharma sponsors, though not Phase 1 oncology focused.

TypeBroad incumbent
Description

Premier academic Phase 1 oncology site; relevant incumbent that anchors sponsor preference for early-phase oncology trials. Indirect competitive pressure on community-based Phase 1 models like P1.

TypeRegional player
Description

Multi-clinic community oncology practice in Washington state with a Phase 1 research program; P1's CMO previously served there. Highly relevant comparable as a community oncology clinic running Phase 1 trials.

TypeOthers
Description

Global early-phase oncology research site network that P1 joined in December 2025 as P1 Pratia Oncology. Functions as both partner and parent strategic operating company, shaping P1's distribution and capabilities.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability2 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature2 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles6 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds2 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

P1 Trials

Clinical Research Servicesp1trials.com

P1 Trials (now P1 Pratia Oncology) is a Seattle-based clinical research site network that enables community oncology clinics to run Phase 1 oncology trials, providing centralized regulatory, financial, technology, and AI patient-matching services to both clinics and pharmaceutical sponsors.

What P1 Trials does

P1 Trials (rebranded as P1 Pratia Oncology in December 2025) is a Seattle-headquartered, Delaware-incorporated clinical research site network that enables community-based oncology clinics to conduct complex Phase 1 oncology trials. The company operates as a managed-services intermediary, providing eight integrated service modules — feasibility assessments, regulatory support, contracts and budgets, financial management, business development, technology integration, quality management, and patient matching/screening — to community oncology practices that lack the infrastructure to run early-phase studies independently. P1 Trials' stated mission is to bring investigational therapies closer to patients outside academic medical centers by bridging sponsor demand with community-site supply.

The platform is built on a centralized infrastructure layer that includes a Clinical Trial Management System (CTMS) and an AI-based patient matching recommendation engine that processes structured patient data to identify relevant trial opportunities across the network. Service delivery is handled through direct enterprise sales to pharmaceutical sponsors and CROs, with industry conferences used as a secondary channel for business development. The customer base is dual-sided: pharmaceutical sponsors seeking faster enrollment and access to community-based patient populations, and community oncology clinics seeking the operational scaffolding, regulatory expertise, and sponsor relationships needed to participate in Phase 1 research.

Revenue is generated through quote-based B2B managed-services arrangements with pharmaceutical sponsors and CROs, monetized via per-trial service fees and centralized operational support for affiliated community clinics. In December 2025, P1 Trials joined Pratia, a global early-phase oncology research site network, and rebranded as P1 Pratia Oncology; Pratia now functions as the parent operating company, granting P1 multi-geography sponsor access and shared operational infrastructure. The company has raised $5,454,015 in an SEC Rule 506(b) exempt equity offering with a single investor, with first sale recorded on November 26, 2025.

P1 Trials firmographics

Firmographics
Name
P1 Trials
Legal name
P1 Trials, Inc.
Website
https://p1trials.com
Company type
Private
Founded year
2024
Operating status
Operating
Headcount range
1–10 employees
Short description
P1 Trials (now P1 Pratia Oncology) is a Seattle-based clinical research site network that enables community oncology clinics to run Phase 1 oncology trials, providing centralized regulatory, financial, technology, and AI patient-matching services to both clinics and pharmaceutical sponsors.
Ownership category
akta.pro rank

P1 Trials industry classification

Industry
Product category
Clinical Research Services
NAICS
Offices of Physicians (62111), Scientific Research and Development Services (5417)
SIC
Services-Health Services (8000), Services-Specialty Outpatient Facilities, Nec (8093)
akta.pro industry
PRIMARYHLAGACAE
Clinical Trial Site Operations & Study Coordination
SECONDARYHLAIALAE
Clinical Development (Phase I–III Trial Design & Execution)
Healthcare & Life Sciences/Pharmaceuticals/Pharmaceutical Research and Development
SECONDARYHLAGACAC
Clinical Site Start-Up & Activation (Regulatory/Ethics/Contracts)
SECONDARYHLAGACAM
Clinical Trial Financial Management & Payments (Site Budgeting)
SECONDARYHLAAANAI
Precision Clinical Trials Enablement (patient matching, site matching, adaptive trials)

Keywords

  • Phase 1 oncology trials
  • Clinical trial site network
  • Community oncology research
  • Patient trial matching
  • Clinical research services

Where P1 Trials is headquartered

Location

Headquarters

HQ city
Seattle
HQ country
United States
HQ region
North America

Offices2 records

Markets served

P1 Trials business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Marketing or Sales

Revenue model

  1. Clinical Trial Support Services: P1 Trials generates revenue by providing centralized services to community oncology clinics conducting Phase 1 clinical trials. Services include feasibility assessments, regulatory support, contracts and budgets, financial management, business development, technology integration, quality management, and patient matching. The company acts as an intermediary between pharmaceutical sponsors seeking trial sites and community clinics seeking trial opportunities.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels2 records

P1 Trials product offering

Product offering

Core offering

P1 Trials operates a centralized, community-based oncology clinic network purpose-built to run Phase 1 clinical trials. It delivers feasibility, regulatory, contracts and budget, financial management, business development, technology integration, quality management, and clinic enablement services, augmented by AI-powered patient matching, giving sponsors access to community oncology patient populations that traditional academic centers typically do not reach.

Product overview

P1 Trials (now P1 Pratia Oncology) operates as a unified platform for Phase 1 oncology clinical trials, combining a network of community-based oncology clinics with centralized infrastructure services. The platform comprises eight integrated service modules: Feasibility Assessments, Regulatory Support, Contracts & Budgets, Financial Management, Business Development, Technology Integration, Quality Management, and Patient Matching & Screening. Together, these services enable community clinics to participate in Phase 1 clinical trials by handling operational complexities, regulatory compliance, financial processes, and patient recruitment—allowing clinics to focus on patient care while the centralized infrastructure manages trial execution.

Differentiator

Problem solved

Functional benefit

Products and services

  • Phase 1 Oncology Clinical Trial Site Network Services

Companies that use P1 Trials

Customer profile

Segments2 records

Ideal customer profiles3 records

P1 Trials technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability2 records

Feature2 records

P1 Trials partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • PratiacoreStrategic or Co-development Partner · 1 December 2025In December 2025, P1 Trials joined Pratia, expanding reach and capabilities as part of a global early-phase oncology Research Site Network. The partnership enables P1 Trials (now P1 Pratia Oncology) to leverage Pratia's global network infrastructure while maintaining its focus on community-based oncology clinics in the US.

Scale indicators2 records

Recent moves5 records

Expansion highlights4 records

P1 Trials competitors and assessment

Company assessment

Direct peers

  • Sarah Cannon Research Institute (SCRI): One of the largest Phase 1 oncology site networks in the US, operating dedicated early-phase units across multiple cities. Directly comparable as a multi-site Phase 1 oncology research organization targeting pharmaceutical sponsors.
  • NEXT Oncology: Network of dedicated Phase 1 oncology centers conducting first-in-human and early-phase trials. Highly comparable business model focused on early-phase oncology trial execution and sponsor access.
  • START (South Texas Accelerated Research Therapeutics): Global early-phase oncology research organization running Phase 1 trials across multiple sites. Directly comparable as a Phase 1-focused oncology site network serving pharma sponsors.
  • Florida Precision Oncology: Phase 1 oncology research site network with multiple community-based locations across Florida. Comparable as a multi-site Phase 1 oncology site operator targeting pharma sponsors.

Emerging players

  • Exigent Research: Innovative research network of independent oncology practices; an advisor to P1 (Sibel Blau, MD) is a founding member. Comparable model aggregating independent community oncology clinics for clinical research.
  • ONCare Alliance: National organization focused on community oncology research, value-based care, and education; P1 leadership has prior involvement. Comparable as a community oncology research network and ecosystem peer.

Broad incumbents

  • IQVIA (Oncology / Site Solutions): Global CRO with dedicated site management and oncology clinical trial services. Comparable as a broad incumbent offering site-network services to pharma sponsors, though not Phase 1 oncology focused.
  • MD Anderson Cancer Center: Premier academic Phase 1 oncology site; relevant incumbent that anchors sponsor preference for early-phase oncology trials. Indirect competitive pressure on community-based Phase 1 models like P1.

Regional players

  • Northwest Medical Specialties: Multi-clinic community oncology practice in Washington state with a Phase 1 research program; P1's CMO previously served there. Highly relevant comparable as a community oncology clinic running Phase 1 trials.

Others

  • Pratia: Global early-phase oncology research site network that P1 joined in December 2025 as P1 Pratia Oncology. Functions as both partner and parent strategic operating company, shaping P1's distribution and capabilities.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

P1 Trials financial estimates

Financial estimate

Revenue estimate

Valuation estimate

P1 Trials leadership team

Management profile

Number of profiles

Profiles6 records

P1 Trials funding detail

Funding detail

Funding overview

Funding rounds2 records

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

P1 Trials M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about P1 Trials

What does P1 Trials do?

P1 Trials operates a centralized, community-based oncology clinic network purpose-built to run Phase 1 clinical trials. It delivers feasibility, regulatory, contracts and budget, financial management, business development, technology integration, quality management, and clinic enablement services, augmented by AI-powered patient matching, giving sponsors access to community oncology patient populations that traditional academic centers typically do not reach.

Is P1 Trials a public or private company?

P1 Trials is a private company. It is classified as corporate owned and is currently operating.

When was P1 Trials founded?

P1 Trials was founded in 2024. It employs 1 to 10 people.

Where is P1 Trials based?

P1 Trials is headquartered in Seattle, United States, in the North America region.

How does P1 Trials make money?

One revenue line is on record: clinical Trial Support Services.

Who are P1 Trials's main competitors?

Direct peers on record are Sarah Cannon Research Institute (SCRI), NEXT Oncology, START (South Texas Accelerated Research Therapeutics) and Florida Precision Oncology. Emerging players are Exigent Research and ONCare Alliance. Broad incumbents are IQVIA (Oncology / Site Solutions) and MD Anderson Cancer Center. Northwest Medical Specialties is listed as a regional player. Pratia is listed as an others.

Does P1 Trials have an API?

No public API is recorded for P1 Trials.

What industry is P1 Trials in?

P1 Trials's product category is Clinical Research Services. Its primary akta.pro industry code is HLAGACAE, Clinical Trial Site Operations & Study Coordination, with a secondary code of HLAIALAE, Clinical Development (Phase I–III Trial Design & Execution). Its NAICS code is 62111 and its SIC code is 8000.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals